DDrare: Database of Drug Development for Rare Diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
299	嚢胞性線維症	1

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00221546 (ClinicalTrials.gov)	September 2007	12/9/2005	Influence of DHA-rich Supplement on DHA-status and Health Evolution of Patients With Cystic Fibrosis	Influence of DHA-rich Supplement on DHA-status and Health Evolution of Patients With Cystic Fibrosis	Cystic Fibrosis	Drug: Giving DHA-rich supplement	University Hospital, Ghent	Belgian Society against Cystic Fibrosis	Completed	6 Years	N/A	Both	17	Phase 2	Belgium

No.

TrialID

Date_
enrollment

Date_
registration

Public_title

Scientific_title

Condition

Intervention

Primary_
sponsor

Secondary_
sponsor

Recruitment_
Status

Inclusion_
agemin

Inclusion_
agemax

Inclusion_
gender

Target_
size

Phase

Countries

September 2007

12/9/2005

Influence of DHA-rich Supplement on DHA-status and Health Evolution of Patients With Cystic Fibrosis

Cystic Fibrosis

Drug: Giving DHA-rich supplement

University Hospital, Ghent

Belgian Society against Cystic Fibrosis

Completed

6 Years

N/A

Both

Phase 2

Belgium